Literature DB >> 21706066

Transplantation: alemtuzumab induction is safe for renal transplant recipients.

Helene Myrvang.   

Abstract

Entities:  

Year:  2011        PMID： 21706066     DOI： 10.1038/nrneph.2011.66

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Alemtuzumab induction in renal transplantation.

Authors:  Michael J Hanaway; E Steve Woodle; Shamkant Mulgaonkar; V Ram Peddi; Dixon B Kaufman; M Roy First; Richard Croy; John Holman
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245
  1 in total
  2 in total

Review 1.  Novel and emerging targeted-based cancer therapy agents and methods.

Authors:  Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-02-09

2.  High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune Suppression.

Authors:  Cyd M Castro-Rojas; Rita R Alloway; E Steve Woodle; David A Hildeman
Journal:  Curr Transplant Rep       Date:  2019-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.